Press monitoring
New Approaches Target Nanoparticles to Cancer Cells
7.6.2006 | Press monitoring
One of the major goals of cancer nanotechnology research is to develop nanoparticles that deliver cancer imaging agents and anticancer drugs specifically to tumors. Two new reports in the literature highlight new approaches to creating targeted nanoscale devices for diagnostic and therapeutic applications in cancer.
Motor proteins sort molecules
7.6.2006 | Press monitoring
Researchers at the Delft University of Technology in the Netherlands have created a fluidic device that can transport molecules and sort them according to their colour. The device contains nanochannels coated with kinesin motor proteins that transport microtubule filaments along the channels. Such biomolecular motor devices could ultimately find a...
Agency Allows Broader Embryo Screening
7.6.2006 | Press monitoring
Parents who use in vitro fertilization in the United Kingdom will be able to test their embryos for inherited forms of cancer, following a decision announced today by the Human Fertilisation and Embryology Authority (HFEA), a government fertility watchdog. Supporters say the decision will help parents prevent potentially lethal illnesses in their...
Researchers see future cure for eye cancer
6.6.2006 | Press monitoring
Investigators at St Jude Children's Research Hospital have discovered the role of several key genes in the development of the retina, and in the process have taken a significant step toward understanding how to prevent or cure the potentially deadly eye cancer retinoblastoma.
Pictures shown for the brain
6.6.2006 | Press monitoring
With functional magnetic resonance imaging, it is not only possible to see cross-sectional images of the human body but also to watch how the brain processes different tasks. A new optical projection system delivers pictures to the test subject inside the scanner.
Development of a microtiter plate-based method for determination of degradation profile of nitrophenolic compounds
5.6.2006 | Press monitoring
A microtiter plate-based assay was developed for the automatic monitoring of degradation profile of the yellow-coloured nitrophenolic compounds.
The potential biomass for energy production in the Czech Republic
5.6.2006 | Press monitoring
Biomass production is a promising alternative for the Czech Republic's (CZ) agricultural sector. Biomass could cover the domestic bio-energy demand of 250 PJ a−1 (predicted for 2030), and could be exported as bio-fuels to other EU countries. This study assesses the CZ's biomass production potential on a regional level and provides...
Genetic study reveals surprises in human evolution
5.6.2006 | Press monitoring
LONDON (Reuters) - Humans' evolutionary split from their closest relatives, chimpanzees, may have been more complicated, taken longer and probably occurred more recently than previously thought, scientists said on Wednesday.
Biogeneric race in Europe heats up
5.6.2006 | Press monitoring
Swiss biopharmaceutical firm Biopartners has got the thumbs up from the European Commission for its biosimilar drug Valtropin, making it only the second biogeneric drug to have been approved in Europe after Sandoz’s Omnitrope received marketing authorisation last month.
A liquid chromatographic-mass spectrometric evidence of dihydrosanguinarine as a first metabolite of sanguinarine transformation in rat.
5.6.2006 | Press monitoring
Psotova J, Klejdus B, Vecera R, Kosina P, Kuban V, Vicar J, Simanek V, Ulrichova J. Institute of Medical Chemistry and Biochemistry, Faculty of Medicine, Palacky University, Olomouc, Czech Republic. Adult rats were orally administered with a single dose of sanguinarine (10 mg SA per 1 kg body weight) in 1.0 ml water. In the plasma and the...
